Inter Partes Review Proceedings
PTAB Portal
IPR Case No(s):
U.S. Patent No.
8,940,878 (Capture Purification Processes for Proteins Expressed in a Non-Mammalian System)
Patent Owner
Amgen Inc.
Petitioner(s)
Kashiv BioSciences, LLC; Amneal Pharmaceuticals, Inc.; Amneal Pharmaceuticals LLC
§ 102 Challenge
Y
Claim Types Challenged Under § 102
Manufacturing
§ 102 Challenge Instituted
Y
§ 103 challenge
Y
Claim Types Challenged Under § 103
Manufacturing
§ 103 Challenge Instituted
Y
Settled / Challenged Claims Disclaimed / Challenge Terminated
Y (Settled After Institution)
IPR Status
Settled After Institution Decision
U.S. Patent No.
9,643,997 (Capture Purification Processes for Proteins Expressed in a Non-Mammalian System)
Patent Owner
Amgen Inc.
Petitioner(s)
Kashiv BioSciences, LLC; Amneal Pharmaceuticals, Inc.; Amneal Pharmaceuticals LLC
§ 102 Challenge
Y
Claim Types Challenged Under § 102
Manufacturing
§ 102 Challenge Instituted
Y
§ 103 challenge
Y
Claim Types Challenged Under § 103
Manufacturing
§ 103 Challenge Instituted
Y
Settled / Challenged Claims Disclaimed / Challenge Terminated
Y (Settled After Institution)
IPR Status
Settled After Institution Decision
U.S. Patent No.
9,856,287 (Refolding Proteins Using a Chemically Controlled Redox State)
Patent Owner
Amgen Inc.; Amgen Manufacturing Ltd.
Petitioner(s)
Adello Biologics, LLC; Amneal Pharmaceuticals, Inc.; Amneal Pharmaceuticals LLC; ApoPharma USA, Inc.; Apotex Corp.; Apotex Holdings, Inc.; Apotex Inc.; Apotex Pharmaceutical Holdings Inc.; Intas Pharmaceuticals Ltd.; Kashiv BioSciences, LLC
§ 102 Challenge
Y
Claim Types Challenged Under § 102
Manufacturing
§ 102 Challenge Instituted
Y
§ 103 challenge
Y
Claim Types Challenged Under § 103
Manufacturing
§ 103 Challenge Instituted
Y
Settled / Challenged Claims Disclaimed / Challenge Terminated
Y (Settled After Institution)
IPR Status
Challenges Also Include Indefiniteness, Written Description, and Enablement. Settled After Institution Decision